G.M. Dallinga-Thie MEng PhD publications

2021

• ter Horst Kasper W., Vatner Daniel F., Zhang Dongyan, Cline Gary W., Ackermans Mariette T., Nederveen Aart J., Verheij Joanne, Demirkiran Ahmet, van Wagensveld Bart A., Dallinga-Thie Geesje M., Nieuwdorp Max, Romijn Johannes A., Shulman Gerald I., Serlie Mireille J. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease Diabetes care 2021;44 (2):489-498 [PubMed]

2020

• Ali Lubna, Cupido Arjen J., Rijkers Maaike, Hovingh G. Kees, Holleboom Adriaan G., Dallinga-Thie Geesje M., Stroes Erik S. G., van den Boogert Marjolein A. W. Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects Atherosclerosis 2020;306:15-21 [PubMed]
• de Groot Pieter, Scheithauer Torsten, Bakker Guido J., Prodan Andrei, Levin Evgeni, Khan Muhammad Tanweer, Herrema Hilde, Ackermans Mariette, Serlie Mireille J. M., de Brauw Maurits, Levels Johannes H. M., Sales Amber, Gerdes Victor E., Ståhlman Marcus, Schimmel Alinda W. M., Dallinga-Thie Geesje, Bergman Jacques Jghm, Holleman Frits, Hoekstra Joost B. L., Groen Albert, Bäckhed Fredrik, Nieuwdorp Max Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time Gut 2020;69:502-512 [PubMed]
• Florijn Barend W., Duijs Jacques M. G. J., Levels Johannes H., Dallinga-Thie Geesje M., Wang Yanan, Boing Anita N., Yuana Yuana, Stam Wendy, Limpens Ronald W. A. L., Au Yu Wah, Nieuwland Rienk, Rabelink Ton J., Reinders Marlies E. J., Jan van Zonneveld Anton, Bijkerk Roel Erratum to: Diabetic nephropathy alters the distribution of circulating angiogenic micrornas among extracellular vesicles, hdl, and ago-2, (Diabetes 2019, 68, 2287-2300) Diabetes 2020;69 (8):1855 [PubMed]
• Bruikman Caroline S., Dalila Nawar, van Capelleveen Julian C., Kroon Jeffrey, Peter Jorge, Havik Stefan R., Willems Martine, Huisman Laurens C., de Boer Onno J., Hovingh G. Kees, Tybjaerg-Hansen Anne, Dallinga-Thie Geesje M. Genetic variants in SUSD2 are associated with the risk of ischemic heart disease Journal of clinical lipidology 2020;14 (4):470-481 [PubMed]
• van den Boogert Marjolein A. W. Glycosylation defects in lipid metabolism 2020. 178p. ISBN 9789463809269. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes Erik S. G., Lefeber D. J.; Co-supervisors: Holleboom Adriaan G., Dallinga-Thie Geesje M.)
• Hartstra Annick V., Schüppel Valentina, Imangaliyev Sultan, Schrantee Anouk, Prodan Andrei, Collard Didier, Levin Evgeni, Dallinga-Thie Geesje, Ackermans Mariette T., Winkelmeijer Maaike, Havik Stefan R., Metwaly Amira, Lagkouvardos Ilias, Nier Anika, Bergheim Ina, Heikenwalder Mathias, Dunkel Andreas, Nederveen Aart J., Liebisch Gerhard, Mancano Giulia, Claus Sandrine P., Benítez-Páez Alfonso, la Fleur Susanne E., Bergman Jacques J., Gerdes Victor, Sanz Yolanda, Booij Jan, Kemper Elles, Groen Albert K., Serlie Mireille J., Haller Dirk, Nieuwdorp Max Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome Molecular metabolism 2020;42 [PubMed]
• de Groot Pieter F., Nikolic Tatjana, Imangaliyev Sultan, Bekkering Siroon, Duinkerken Gaby, Keij Fleur M., Herrema Hilde, Winkelmeijer Maaike, Kroon Jeffrey, Levin Evgeni, Hutten Barbara, Kemper Elles M., Simsek Suat, Levels Johannes H. M., van Hoorn Flora A., Bindraban Renuka, Berkvens Alicia, Dallinga-Thie Geesje M., Davids Mark, Holleman Frits, Hoekstra Joost B. L., Stroes Erik S. G., Netea Mihai, van Raalte Daniël H., Roep Bart O., Nieuwdorp Max Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial Diabetologia 2020;63 (3):597-610 [PubMed]
• Meessen Emma C. E., Bakker Guido J., Nieuwdorp Max, Dallinga-Thie Geesje M., Kemper E. Marleen, Olde Damink Steven W., Romijn Johannes A., Hartmann Bolette, Holst Jens J., Knop Filip K., Groen Albert K., Schaap Frank G., Soeters Maarten R. Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy men Clinical nutrition (Edinburgh, Scotland) 2020 [PubMed]
• Loaiza Natalia, Hartgers Merel L., Reeskamp Laurens F., Balder Jan-Willem, Rimbert Antoine, Bazioti Venetia, Wolters Justina C., Winkelmeijer Maaike, Jansen Hans P. G., Dallinga-Thie Geesje M., Volta Andrea, Huijkman Nicolette, Smit Marieke, Kloosterhuis Niels, Koster Mirjam, Svendsen Arthur F., van de Sluis Bart, Hovingh G. Kees, Grefhorst Aldo, Kuivenhoven Jan Albert Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans Arteriosclerosis, thrombosis, and vascular biology 2020;40 (4):973-985 [PubMed]
• Nurmohamed N. S., Dallinga–Thie G. M., Stroes E. S. G. Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia Expert review of cardiovascular therapy 2020;18 (6):355-361 [PubMed]
• Bouter Kristien E. C., van Bommel Erik J. M., Jansen Hans, van Harskamp Dewi, Schierbeek Henk, Ackermans Mariëtte T., Serlie Mireille J., Schimmel Alinda W. M., Nieuwdorp Max, Dallinga-Thie Geesje M., van Raalte Daniël H. The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol Diabetes, obesity & metabolism 2020;22 (6):988-996 [PubMed]
• Binder Christoph J., Borén Jan, Catapano Alberico L., Dallinga-Thie Geesje, Kronenberg Florian, Mallat Ziad, Negrini Simona, Raggi Paolo, von Eckardstein Arnold The year 2019 in Atherosclerosis Atherosclerosis 2020;299:67-75 [PubMed]

2019

• Verbeek Rutger, Oldoni Federico, Surendran R. Preethi, Zwinderman Ailko H., Khaw Kay T., Stroes Erik S. G., Wareham Nick J., Boekholdt S. Matthijs, Dallinga-Thie Geesje M. A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk Journal of clinical lipidology 2019;13 (3):492-501 [PubMed]
• Florijn Barend W., Duijs Jacques M. G. J., Levels Johannes H., Dallinga-Thie Geesje M., Wang Yanan, Boing Anita N., Yuana Yuana, Stam Wendy, Limpens Ronald W. A. L., Au Yu Wah, Nieuwland Rienk, Rabelink Ton J., Reinders Marlies E. J., van Zonneveld Anton Jan, Bijkerk Roel Diabetic Nephropathy Alters the Distribution of Circulating Angiogenic MicroRNAs Among Extracellular Vesicles, HDL, and Ago-2 Diabetes 2019;68 (12):2287-2300 [PubMed]
• van den Hof Malon, Haneveld Mirthe J. Klein, Blokhuis Charlotte, Scherpbier Henriette J., Jansen Hans P. G., Kootstra Neeltje A., Dallinga-Thie Geesje M., van Deventer Sander J. H., Tsimikas Sotirios, Pajkrt Dasja, van den Hof M., Blokhuis C., Cohen S., Pajkrt D., Scherpbier H. J., Kuijpers T. W., van der Plas A., Weijsenfeld A., ter Stege J. S., Kootstra N. A., Caan M. W. A., Mutsaerts H. J. M. M., Majoie C. B. L. M., Verbraak F. D., Schmand B., Geurtsen G., Mathot R. A. A., Wit F. W. N. M., Reiss P., Teunissen C. E., Kuhle J., Meijer J. C. M. Elevated Lipoprotein(a) in Perinatally HIV-Infected Children Compared with Healthy Ethnicity-Matched Controls Open forum infectious diseases 2019;6 (9) [PubMed]
• de Winther Menno P. J., Dallinga-Thie Geesje M. Introduction to the thematic review series on different levels of genetic regulation of cardiovascular disease Atherosclerosis 2019;281:148-149 [PubMed]
• Surendran Ramya Preethi Molecular metabolism underlying hypertriglyceridemia: From bench to bedside 2019. 176p. ISBN 9789402814354. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Nieuwdorp M.; Co-supervisor: Dallinga-Thie G.)
• van den Boogert Marjolein A. W., Larsen Lars E., Ali Lubna, Kuil Sacha D., Chong Patrick L. W., Loregger Anke, Kroon Jeffrey, Schnitzler Johan G., Schimmel Alinda W. M., Peter Jorge, Levels Johannes H. M., Steenbergen Gerry, Morava Eva, Dallinga-Thie Geesje M., Wevers Ron A., Kuivenhoven Jan Albert, Hand Nicholas J., Zelcer Noam, Rader Daniel J., Stroes Erik S. G., Lefeber Dirk J., Holleboom Adriaan G. N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression Circulation 2019;140 (4):280-292 [PubMed]
• Bakker Guido J., Schnitzler Johan G., Bekkering Siroon, de Clercq Nicolien C., Koopen Annefleur M., Hartstra Annick V., Meessen Emma C. E., Scheithauer Torsten P., Winkelmeijer Maaike, Dallinga-Thie Geesje M., Cani Patrice D., Kemper Elles Marleen, Soeters Maarten R., Kroon Jeffrey, Groen Albert K., van Raalte Daniël H., Herrema Hilde, Nieuwdorp Max Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects Physiological reports 2019;7 (16) [PubMed]
• Nicorescu Ioana, Dallinga Geesje M., de Winther Menno P. J., Stroes Erik S. G., Bahjat Mahnoush Potential epigenetic therapeutics for atherosclerosis treatment Atherosclerosis 2019;281:189-197 [PubMed]
• van den Boogert Marjolein A. W., Crunelle Cleo L., Ali Lubna, Larsen Lars E., Kuil Sacha D., Levels Johannes H. M., Schimmel Alinda W. M., Konstantopoulou Vassiliki, Guerin Maryse, Kuivenhoven Jan Albert, Dallinga-Thie Geesje M., Stroes Erik S. G., Lefeber Dirk J., Holleboom Adriaan G. Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations Journal of inherited metabolic disease 2019 [PubMed]
• Schnitzler Johan G., Dallinga-Thie Geesje M., Kroon Jeffrey The role of (Modified) lipoproteins in vascular function: A duet between monocytes and the endothelium Current medicinal chemistry 2019;26 (9):1594-1609 [PubMed]

2018

• Reeskamp Laurens F., Hartgers Merel L., Peter Jorge, Dallinga-Thie Geesje M., Zuurbier Linda, Defesche Joep C., Grefhorst Aldo, Hovingh G. Kees A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia Circulation. Genomic and precision medicine 2018;11 (12):e002385 [PubMed]
• Nahon Joya E., Hoekstra Menno, Havik Stefan R., van Santbrink Peter J., Dallinga-Thie Geesje M., Kuivenhoven Jan-Albert, Geerling Janine J., van Eck Miranda Corrigendum to “Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.” [Atherosclerosis 274 (July 2018) 120–127] Atherosclerosis 2018;279:132 [PubMed]
• Surendran R. Preethi, Udayyapan Shanti D., Clemente-Postigo Mercedes, Havik Stefan R., Schimmel Alinda W. M., Tinahones Fransisco, Nieuwdorp Max, Dallinga-Thie Geesje M. Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance PLoS ONE 2018;13 (11) [PubMed]
• Bouter K. E. C., Bakker G. J., Levin E., Hartstra A. V., Kootte R. S., Udayappan S. D., Katiraei S., Bahler L., Gilijamse P. W., Tremaroli V., Stahlman M., Holleman F., van Riel N. A. W., Verberne H. J., Romijn J. A., Dallinga-Thie G. M., Serlie M. J., Ackermans M. T., Kemper E. M., Willems van Dijk K., Backhed F., Groen A. K., Nieuwdorp M. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects article Clinical and translational gastroenterology 2018;9 (5) [PubMed]
• Smits Loek P., Kootte Ruud S., Levin Evgeni, Prodan Andrei, Fuentes Susana, Zoetendal Erwin G., Wang Zeneng, Levison Bruce S., Cleophas Maartje C. P., Kemper E. Marleen, Dallinga-Thie Geesje M., Groen Albert K., Joosten Leo A. B., Netea Mihai G., Stroes Erik S. G., de Vos Willem M., Hazen Stanley L., Nieuwdorp Max Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome Journal of the American Heart Association 2018;7 (7) [PubMed]
• Udayappan Shantha D. Gut microbiota in relation to pathogenesis of obesity and type 2 diabetes 2018. 178p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisors: Dallinga-Thie G. M., Herrema H. J.)
• Oldoni Federico, van Capelleveen Julian C., Dalila Nawar, Wolters Justina C., Heeren Joerg, Sinke Richard J., Hui David Y., Dallinga-Thie Geesje M., Frikke-Schmidt Ruth, Hovingh Kees G., van de Sluis Bart, Tybjærg-Hansen Anne, Kuivenhoven Jan Albert Naturally occurring variants in LRP1 (Low-Density lipoprotein receptor-related protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans Arteriosclerosis, thrombosis, and vascular biology 2018;38 (7):1440-1453 [PubMed]
• Nahon Joya E., Hoekstra Menno, Havik Stefan R., van Santbrink Peter J., Dallinga-Thie Geesje M., Kuivenhoven Jan-Albert, Geerling Janine J., van Eck Miranda Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model Atherosclerosis 2018;274:120-127 [PubMed]
• Kootte Ruud S. The role of the intestine in human glucose and lipid metabolism: Source for novel targets in the prevention of cardiometabolic disease 2018. ISBN 9789462339460. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Dallinga-Thie G. M.)
• Zhang Xiang, Rimbert Antoine, Balder Willem, Zwinderman Aeilko Having, Kuivenhoven Jan Albert, Dallinga-Thie Geesje Margaretha, Groen Albert Kornelis Use of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females Journal of lipid research 2018;59 (11):2174-2180 [PubMed]

2017

• Trigueros-Motos Laia, van Capelleveen Julian C., Torta Federico, Castaño David, Zhang Lin-Hua, Chai Ee Chu, Kang Martin, Dimova Lidiya G., Schimmel Alinda W. M., Tietjen Ian, Radomski Chris, Tan Liang Juin, Thiam Chung Hwee, Narayanaswamy Pradeep, Wu Daniel Heqing, Dorninger Fabian, Yakala Gopala Krishna, Barhdadi Amina, Angeli Veronique, Dubé Marie-Pierre, Berger Johannes, Dallinga-Thie Geesje M., Tietge Uwe J. F., Wenk Markus R., Hayden Michael R., Hovingh G. Kees, Singaraja Roshni R. ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels Arteriosclerosis, thrombosis, and vascular biology 2017;37 (11):2147-2155 [PubMed]
• Hu Xuchen, Dallinga-Thie Geesje M., Hovingh G. Kees, Chang Sandy Y., Sandoval Norma P., Dang Tiffany Ly P., Fukamachi Isamu, Miyashita Kazuya, Nakajima Katsuyuki, Murakami Masami, Fong Loren G., Ploug Michael, Young Stephen G., Beigneux Anne P. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia Journal of clinical lipidology 2017;11 (4):964-971 [PubMed]
• Ganjali Shiva, Dallinga-Thie Geesje M., Simental-Mendía Luis E., Banach Maciej, Pirro Matteo, Sahebkar Amirhossein HDL functionality in type 1 diabetes Atherosclerosis 2017;267:99-109 [PubMed]
• van Capelleveen Julian C. Identification and targeting of genes in atherosclerosis 2017. 342p. ISBN 9789462997585. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Hovingh G. K.; Co-supervisor: Dallinga-Thie G. M.)
• Kootte Ruud S., Levin Evgeni, Salojärvi Jarkko, Smits Loek P., Hartstra Annick V., Udayappan Shanti D., Hermes Gerben, Bouter Kristien E., Koopen Annefleur M., Holst Jens J., Knop Filip K., Blaak Ellen E., Zhao Jing, Smidt Hauke, Harms Amy C., Hankemeijer Thomas, Bergman Jacques J. G. H. M., Romijn Hans A., Schaap Frank G., Olde Damink Steven W. M., Ackermans Mariette T., Dallinga-Thie Geesje M., Zoetendal Erwin, de Vos Willem M., Serlie Mireille J., Stroes Erik S. G., Groen Albert K., Nieuwdorp Max Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition Cell metabolism 2017;26 (4):611-619-e6 [PubMed]
• Udayappan Shanthadevi D., Kovatcheva-Datchary Petia, Bakker Guido J., Havik Stefan R., Herrema Hilde, Cani Patrice D., Bouter Kristien E., Belzer Clara, Witjes Julia J., Vrieze Anne, de Sonnaville Noor, Chaplin Alice, van Raalte Daniel H., Aalvink Steven, Dallinga-Thie Geesje M., Heilig Hans G. H. J., Bergström Göran, van der Meij Suzan, van Wagensveld Bart A., Hoekstra Joost B. L., Holleman Frits, Stroes Erik S. G., Groen Albert K., Bäckhed Fredrik, de Vos Willem M., Nieuwdorp Max Intestinal Ralstonia pickettii augments glucose intolerance in obesity PLoS ONE 2017;12 (11) [PubMed]
• de Winther Menno, Dallinga-Thie Geesje, Kuipers Folkert Marten Hofker (1956-2016) Arteriosclerosis, thrombosis, and vascular biology 2017;37 (1):5-6 [PubMed]
• Schnitzler Johan G., Bernelot Moens Sophie J., Tiessens Feiko, Bakker Guido J., Dallinga-Thie Geesje M., Groen Albert K., Nieuwdorp Max, Stroes Erik S. G., Kroon Jeffrey Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient- derived circulating monocytes using confocal microscopy Journal of lipid research 2017;58 (11):2210-2219 [PubMed]

2016

• Motazacker Mahdi M., Pirhonen Juho, van Capelleveen Julian C., Weber-Boyvat Marion, Kuivenhoven Jan Albert, Shah Saundarya, Hovingh G. Kees, Metso Jari, Li Shiqian, Ikonen Elina, Jauhiainen Matti, Dallinga-Thie Geesje M., Olkkonen Vesa M. A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity Atherosclerosis 2016;249:140-147 [PubMed]
• Maiwald Stephanie, Motazacker Mahdi M., van Capelleveen Julian C., Sivapalaratnam Suthesh, van der Wal Allard C., van der Loos Chris, Kastelein John J. P., Ouwehand Willem H., Hovingh G. Kees, Trip Mieke D., van Buul Jaap D., Dallinga-Thie Geesje M. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis European journal of human genetics 2016;24 (1):86-91 [PubMed]
• Bernelot Moens Sophie J. Cardiovascular disease beyond traditional risk factors: Balancing lipids and inflammation 2016. 253p. ISBN 9789462334588. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Dallinga-Thie G. M.)
• Scheithauer Torsten P. M., Dallinga-Thie Geesje M., de Vos Willem M., Nieuwdorp Max, van Raalte Daniël H. Causality of small and large intestinal microbiota in weight regulation and insulin resistance Molecular metabolism 2016;5 (9):759-770 [PubMed]
• van Tienhoven-Wind L. J. N., Dallinga-Thie G. M., Dullaart R. P. F. Higher Plasma ApoE Levels are Associated with Low-Normal Thyroid Function: Studies in Diabetic and Nondiabetic Subjects Hormone and metabolic research. Hormon- und Stoffwechselforschung. Hormones et metabolisme 2016;48 (7):462-467 [PubMed]
• de Winther Menno, Dallinga-Thie Geesje, Kuipers Folkert In memoriam: Marten Hofker (1956-2016) Atherosclerosis 2016;255:109-110 [PubMed]
• van der Valk Fleur M., Schulte Dominik M., Meiler Svenja, Tang Jun, Zheng Kang He, van den Bossche Jan, Seijkens Tom, Laudes Matthias, de Winther Menno, Lutgens Esther, Alaarg Amr, Metselaar Josbert M., Dallinga-Thie Geesje M., Mulder Willem J. M., Stroes Erik S. G., Hamers Anouk A. J. Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis Nanomedicine: nanotechnology, biology and medicine 2016;12 (6):1463-1470 [PubMed]
• Udayappan Shanthadevi, Manneras-Holm Louise, Chaplin-Scott Alice, Belzer Clara, Herrema Hilde, Dallinga-Thie Geesje M., Duncan Silvia H., Stroes Erik S. G., Groen Albert K., Flint Harry J., Backhed Fredrik, de Vos Willem M., Nieuwdorp Max Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice NPJ biofilms and microbiomes 2016;2:16009 [PubMed]
• Dullaart Robin P. F., Gruppen Eke G., Dallinga-Thie Geesje M. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles Clinical biochemistry 2016;49 (6):508-510 [PubMed]
• Thedrez Aurélie, Sjouke Barbara, Passard Maxime, Prampart-Fauvet Simon, Guédon Alexis, Croyal Mikael, Dallinga-Thie Geesje, Peter Jorge, Blom Dirk, Ciccarese Milco, Cefalù Angelo B., Pisciotta Livia, Santos Raul D., Averna Maurizio, Raal Frederick, Pintus Paolo, Cossu Maria, Hovingh Kees, Lambert Gilles Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report Arteriosclerosis, thrombosis, and vascular biology 2016;36 (8):1647-1650 [PubMed]
• Dallinga Marchien G., Dallinga-Thie Geesje M. Role of sulfatase 2 in lipoprotein metabolism and angiogenesis Current opinion in lipidology 2016;27 (2):181-186 [PubMed]
• Dallinga-Thie Geesje M., Kroon Jeffrey, Borén Jan, Chapman M. John Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy? Current cardiology reports 2016;18 (7):67 [PubMed]

2015

• Frisdal Eric, Le Lay Soazig, Hooton Henri, Poupel Lucie, Olivier Maryline, Alili Rohia, Plengpanich Wanee, Villard Elise F., Gilibert Sophie, Lhomme Marie, Superville Alexandre, Miftah-Alkhair Lobna, Chapman M. John, Dallinga-Thie Geesje M., Venteclef Nicolas, Poitou Christine, Tordjman Joan, Lesnik Philippe, Kontush Anatol, Huby Thierry, Dugail Isabelle, Clement Karine, Guerin Maryse, Le Goff Wilfried Adipocyte ATP-Binding Cassette Gal Promotes Triglyceride Storage, Fat Mass Growth, and Human Obesity Diabetes 2015;64 (3):840-855 [PubMed]
• Hiddink Larissa, Dallinga-Thie Geesje M., Hovingh G. Kees, de Visser Marieke C. H., Peer Petronella G. M., Stalenhoef Anton F. H., van Heerde Waander L. Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease risk Atherosclerosis 2015;238 (2):195-200 [PubMed]
• Kootte Ruud S., Smits Loek P., van der Valk Fleur M., Dasseux Jean-Louis, Keyserling Constance H., Barbaras Ronald, Paolini John F., Santos Raul D., van Dijk Theo H., Dallinga-van Thie Geesje M., Nederveen Aart J., Mulder Willem J. M., Hovingh G. Kees, Kastelein John J. P., Groen Albert K., Stroes Erik S. Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA Journal of lipid research 2015;56 (3):703-712 [PubMed]
• Mooij Hans L., Bernelot Moens Sophie J., Gordts Philip L. S. M., Stanford Kristin I., Foley Erin M., van den Boogert Marjolein A. W., Witjes Julia J., Hassing H. Carlijne, Tanck Michael W., van de Sande Michiel A. J., Levels J. Han, Kastelein John J. P., Stroes Erik S. G., Dallinga-Thie Geesje M., Esko Jeff D., Nieuwdorp Max Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans Journal of lipid research 2015;56 (3):665-673 [PubMed]
• Mooij Hans Leonard Functional consequences of inborn and acquired errors in endothelial glycocalyx heparan sulfates 2015. 212p. ISBN 9789461825476. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Vink H.; Co-supervisors: Nieuwdorp M., Dallinga-Thie G. M.)
• Dallinga-Thie Geesje M., Nieuwdorp Max GLP1, an Important Regulator of Intestinal Lipid Metabolism Arteriosclerosis, thrombosis, and vascular biology 2015;35 (5):1048-1049 [PubMed]
• Dullaart Robin P. F., de Vries Rindert, Kwakernaak Arjan J., Perton Frank, Dallinga-Thie Geesje M. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes European journal of clinical investigation 2015;45 (1):36-44 [PubMed]
• de Guia Roldan M., Rose Adam J., Sommerfeld Anke, Seibert Oksana, Strzoda Daniela, Zota Annika, Feuchter Yvonne, Krones-Herzig Anja, Sijmonsma Tjeerd, Kirilov Milen, Sticht Carsten, Gretz Norbert, Dallinga-Thie Geesje, Diederichs Sven, Klöting Nora, Blüher Matthias, Berriel Diaz Mauricio, Herzig Stephan microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis EMBO journal 2015;34 (3):344-360 [PubMed]
• Tsikas Dimitrios, Pham Vu Vi, Suchy Maria-Theresia, van de Ree Marcel A., Huisman Menno V., Frölich Jürgen C., Princen Hans M. G., Berk-Planken I., Hoogerbrugge N., Jansen H., Princen H. M. G., Huisman M. V., van de Ree M. A., Stolk R. P., van Venrooij F. V., Banga J. D., Dallinga-Thie G. No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study Pharmacological research 2015;94:1-8 [PubMed]
• Abbasi Ali, Dallinga-Thie Geesje M., Dullaart Robin P. F. Phospholipid transfer protein activity and incident type 2 diabetes mellitus Clinica chimica acta; international journal of clinical chemistry 2015;439:38-41 [PubMed]
• van der Valk Fleur M., van Wijk Diederik F., Lobatto Mark E., Verberne Hein J., Storm Gert, Willems Martine C. M., Legemate Dink A., Nederveen Aart J., Calcagno Claudia, Mani Venkatesh, Ramachandran Sarayu, Paridaans Maarten P. M., Otten Maarten J., Dallinga-Thie Geesje M., Fayad Zahi A., Nieuwdorp Max, Schulte Dominik M., Metselaar Josbert M., Mulder Willem J. M., Stroes Erik S. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration Nanomedicine: nanotechnology, biology and medicine 2015;11 (5):1039-1046 [PubMed]
• Maiwald Stephanie Rare genetic variants associated with early onset CVD 2015. 208p. ISBN 9789462037502. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Ouwehand W. H.; Co-supervisors: Trip M. D., Dallinga-Thie G., Hovingh G. K.)

2014

• Maiwald S., Oey R. C., Sivapalaratnam S., Bakhtiari K., Hovingh G. K., Basart D. C. G., Trip M. D., Dallinga-Thie G. M. Abnormal hemostatic parameters in patients with myocardial infarction but angiographically normal coronary arteries International journal of cardiology 2014;174 (3):734-735 [PubMed]
• Bochem Andrea E., Holleboom Adriaan G., Romijn Johannes A., Hoekstra Menno, Dallinga Geesje M., Motazacker Mahdi M., Hovingh G. Kees, Kuivenhoven Jan A., Stroes Erik S. G. Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT PLoS ONE 2014;9 (5):e90967 [PubMed]
• Rensing Katrijn L., de Jager Saskia C. A., Stroes Erik S., Vos Mariska, Twickler Marcel Th B., Dallinga-Thie Geesje M., de Vries Carlie J. M., Kuiper Johan, Bot Ilze, von der Thüsen Jan H. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice Cardiovascular research 2014;101 (2):277-287 [PubMed]
• Bernelot Moens Sophie J., Mooij Hans L., Hassing H. Carlijne, Kruit Janine K., Witjes Julia J., van de Sande Michiel A. J., Nederveen Aart J., Xu Ding, Dallinga-Thie Geesje M., Esko Jeffrey D., Stroes Erik S. G., Nieuwdorp Max Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume PLoS ONE 2014;9 (12):e115662 [PubMed]
• Colin Sophie, Fanchon Mélanie, Belloy Loic, Bochem Andrea E., Copin Corinne, Derudas Bruno, Stroes Erik S. G., Hovingh G. Kees, Kuivenhoven Jan A., Dallinga-Thie Geesje M., Staels Bart, Chinetti-Gbaguidi Giulia HDL does not influence the polarization of human monocytes toward an alternative phenotype International journal of cardiology 2014;172 (1):179-184 [PubMed]
• Jäger Julia, Greiner Vera, Strzoda Daniela, Seibert Oksana, Niopek Katharina, Sijmonsma Tjeerd P., Schäfer Michaela, Jones Allan, de Guia Roldan, Martignoni Marc, Dallinga-Thie Geesje M., Diaz Mauricio B., Hofmann Thomas G., Herzig Stephan Hepatic transforming growth factor-beta 1 stimulated clone-22 D1 controls systemic cholesterol metabolism Molecular metabolism 2014;3 (2):155-166 [PubMed]
• Vrieze Anne, Out Carolien, Fuentes Susana, Jonker Lisanne, Reuling Isaie, Kootte Ruud S., van Nood Els, Holleman Frits, Knaapen Max, Romijn Johannes A., Soeters Maarten R., Blaak Ellen E., Dallinga-Thie Geesje M., Reijnders Dorien, Ackermans Mariette T., Serlie Mireille J., Knop Filip K., Holst Jenst J., van der Ley Claude, Kema Ido P., Zoetendal Erwin G., de Vos Willem M., Hoekstra Joost B. L., Stroes Erik S., Groen Albert K., Nieuwdorp Max Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity Journal of hepatology 2014;60 (4):824-831 [PubMed]
• Udayappan S. D., Hartstra A. V., Dallinga-Thie G. M., Nieuwdorp M. Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus Clinical and experimental immunology 2014;177 (1):24-29 [PubMed]
• Mooij H. L., Cabrales P., Bernelot Moens S. J., Xu D., Udayappan S. D., Tsai A. G., van der Sande M. A. J., de Groot E., Intaglietta M., Kastelein J. J. P., Dallinga-Thie G. M., Esko J. D., Stroes E. S., Nieuwdorp M. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function Journal of the American Heart Association 2014;3 (6):e001274 [PubMed]
• Maiwald Stephanie, Sivapalaratnam Suthesh, Motazacker Mahdi M., van Capelleveen Julian C., Bot Ilze, de Jager Saskia C., van Eck Miranda, Jolley Jennifer, Kuiper Johan, Stephens Jonathon, Albers Cornelius A., Vosmeer C. Ruben, Kruize Heleen, Geerke Daan P., van der Wal Allard C., van der Loos Chris M., Kastelein John J. P., Trip Mieke D., Ouwehand Willem H., Dallinga-Thie Geesje M., Hovingh G. Kees Mutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis PLoS ONE 2014;9 (5):e98289 [PubMed]
• Fouchier Sigrid W., Dallinga-Thie Geesje M., Meijers Joost C. M., Zelcer Noam, Kastelein John J. P., Defesche Joep C., Hovingh G. Kees Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia Circulation research 2014;115 (6):552-555 [PubMed]
• Hassing H. Carlijne, Surendran R. Preethi, Derudas Bruno, Verrijken An, Francque Sven M., Mooij Hans L., Bernelot Moens Sophie J., Hart Leen M. 't, Nijpels Giel, Dekker Jacqueline M., Williams Kevin Jon, Stroes Erik S. G., van Gaal Luc F., Staels Bart, Nieuwdorp Max, Dallinga-Thie Geesje M. SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus Obesity (Silver Spring, Md.) 2014;22 (5):1309-1316 [PubMed]
• Hoeksema Marten A., Gijbels Marion J. J., van den Bossche Jan, van der Velden Saskia, Sijm Ayestha, Neele Annette E., Seijkens Tom, Stöger J. Lauran, Meiler Svenja, Boshuizen Marieke C. S., Dallinga-Thie Geesje M., Levels Johannes H. M., Boon Louis, Mullican Shannon E., Spann Nathanael J., Cleutjens Jack P., Glass Chris K., Lazar Mitchell A., de Vries Carlie J. M., Biessen Erik A. L., Daemen Mat J. A. P., Lutgens Esther, de Winther Menno P. J. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions EMBO molecular medicine 2014;6 (9):1124-1132 [PubMed]
• Fryer Lee G. D., Jones Bethan, Duncan Emma J., Hutchison Claire E., Ozkan Tozen, Williams Paul A., Alder Olivia, Nieuwdorp Max, Townley Anna K., Mensenkamp Arjen R., Stephens David J., Dallinga-Thie Geesje M., Shoulders Carol C. The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis Journal of biological chemistry 2014;289 (7):4244-4261 [PubMed]
• Dallinga-Thie G. M., Hovingh G. K. Towards network analysis to understand the genetic architecture of blood lipids: Do the inclusion of age-dependency helps to identify seven novel loci? Atherosclerosis 2014;235 (2):642-643 [PubMed]
• Bochem A. E., van Capelleveen J. C., Dallinga-Thie G. M., Schimmel A. W. M., Motazacker M. M., Tietjen I., Singaraja R. R., Hayden M. R., Kastelein J. J. P., Stroes E. S. G., Hovingh G. K. Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families Clinical genetics 2014;85 (5):433-440 [PubMed]

2013

• Bochem Andrea E., van Wijk Diederik F., Holleboom Adriaan G., Duivenvoorden Raphaël, Motazacker Mahdi M., Dallinga-Thie Geesje M., de Groot Eric, Kastelein John J. P., Nederveen Aart J., Hovingh G. Kees, Stroes Erik S. G. ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden European heart journal 2013;34 (4):286-291 [PubMed]
• Hassing H. Carlyne Glycobiology in cardiometabolic homeostasis 2013. 227p. ISBN 9789461917355. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Nieuwdorp M., Dallinga-Thie G. M.)
• Bochem Andrea E., Holleboom Adriaan G., Romijn Johannes A., Hoekstra Menno, Dallinga-Thie Geesje M., Motazacker Mahdi M., Hovingh G. Kees, Kuivenhoven Jan A., Stroes Erik S. G. High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C Journal of lipid research 2013;54 (6):1698-1704 [PubMed]
• Bernelot Moens Sophie J., Hassing Carlijne H., Nieuwdorp Max, Stroes Erik S. G., Dallinga-Thie Geesje M. Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies Clinical lipidology 2013;8 (3):321-328
• Sorrentino Vincenzo, Fouchier Sigrid W., Motazacker Mohammad M., Nelson Jessica K., Defesche Joep C., Dallinga-Thie Geesje M., Kastelein John J. P., Kees Hovingh G., Zelcer Noam Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein European heart journal 2013;34 (17):1292-1297 [PubMed]
• Sondermeijer Brigitte M., Battjes Suzanne, van Dijk Theo H., Ackermans Mariëtte T., Serlie Mireille J., Nieuwdorp Max, Groen Albert K., Dallinga-Thie Geesje M., Stroes Erik S. G. Lactate increases hepatic secretion of VLDL-triglycerides in humans Atherosclerosis 2013;228 (2):443-450 [PubMed]
• Triolo Michela, Kwakernaak Arjan J., Perton Frank G., de Vries Rindert, Dallinga-Thie Geesje M., Dullaart Robin P. F. Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus Atherosclerosis 2013;228 (2):466-471 [PubMed]
• Maiwald Stephanie, Zwetsloot Peter-Paul, Sivapalaratnam Suthesh, Dallinga-Thie Geesje M. Monocyte gene expression and coronary artery disease Current opinion in clinical nutrition and metabolic care 2013;16 (4):411-417 [PubMed]
• Knaapen M., Kootte R. S., Zoetendal E. G., de Vos W. M., Dallinga-Thie G. M., Levi M. [=Marcel M.], Stroes E. S., Nieuwdorp M. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clinical microbiology and infection 2013;19 (4):331-337 [PubMed]
• Dullaart R. P. F., van Tol A., Dallinga-Thie G. M. Phospholipid transfer protein, an emerging cardiometabolic risk marker: is it time to intervene? Atherosclerosis 2013;228 (1):38-41 [PubMed]
• Strang Aart C., Bisoendial Radjesh J., Kootte Ruud S., Schulte Dominik M., Dallinga-Thie Geesje M., Levels Johannes H. M., Kok Marc, Vos Koen, Tas Sander W., Tietge Uwe J. F., Müller Nike, Laudes Matthias, Gerlag Danielle M., Stroes Erik S. G., Tak Paul P. Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis Atherosclerosis 2013;229 (1):174-181 [PubMed]
• Singaraja Roshni R., Sivapalaratnam Suthesh, Hovingh Kees, Dubé Marie-Pierre, Castro-Perez José, Collins Heidi L., Adelman Steven J., Riwanto Meliana, Manz Jasmin, Hubbard Brian, Tietjen Ian, Wong Kenny, Mitnaul Lyndon J., van Heek Margaret, Lin Linus, Roddy Thomas A., McEwen Jason, Dallinge-Thie Geesje, van Vark-van der Zee Leonie, Verwoert Germaine, Winther Michael, van Duijn Cornelia, Hofman Albert, Trip Mieke D., Marais A. David, Asztalos Bela, Landmesser Ulf, Sijbrands Eric, Kastelein John J., Hayden Michael R. The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans Circulation. Cardiovascular genetics 2013;6 (1):54-62 [PubMed]
• Dullaart Robin P. F., Kwakernaak Arjan J., Dallinga-Thie Geesje M. The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome Atherosclerosis 2013;230 (1):6-11 [PubMed]
• Jones Allan, Friedrich Kilian, Rohm Maria, Schäfer Michaela, Algire Carolyn, Kulozik Philipp, Seibert Oksana, Müller-Decker Karin, Sijmonsma Tjeerd, Strzoda Daniela, Sticht Carsten, Gretz Norbert, Dallinga-Thie Geesje M., Leuchs Barbara, Kögl Manfred, Stremmel Wolfgang, Diaz Mauricio Berriel, Herzig Stephan TSC22D4 is a molecular output of hepatic wasting metabolism EMBO molecular medicine 2013;5 (2):294-308 [PubMed]
• Jones A., Friedrich K., Rohm M., Schaefer M., Algire C., Kulozik P., Seibert O., Mueller-Decker K., Sijmonsma T., Strzoda D., Sticht C., Gretz N., Dallinga-Thie G. M., Leuchs B., Koegl M., Stremmel W., Diaz Berriel M., Herzig S. TSC22D4 is a molecular output of hepatic wasting metabolism (vol 5, pg 294, 2013) EMBO molecular medicine 2013;5 (6):965

2012

• Visser M. E., Dallinga-Thie G. M., Pinto-Sietsma S. J., Defesche J. C., Stroes E. S., van der Valk P. R. APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required Netherlands journal of medicine 2012;70 (6):278-280 [PubMed]
• Olivier Maryline, Tanck Michael W., Out Ruud, Villard Elise F., Lammers Bart, Bouchareychas Laura, Frisdal Eric, Superville Alexandre, van Berkel Theo, Kastelein John J., Eck Miranda Van, Jukema J. Wouter, Chapman M. John, Dallinga-Thie Geesje M., Guerin Maryse, Goff Wilfried Le Human ATP-Binding Cassette G1 Controls Macrophage Lipoprotein Lipase Bioavailability and Promotes Foam Cell Formation Arteriosclerosis, thrombosis, and vascular biology 2012;32 (9):2223-+ [PubMed]
• Orsoni Alexina, Villard Elise F., Bruckert Eric, Robillard Paul, Carrie Alain, Bonnefont-Rousselot Dominique, Chapman M. John, Dallinga-Thie Geesje M., Le Goff Wilfried, Guerin Maryse Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia Journal of lipid research 2012;53 (4):767-775 [PubMed]
• Sondermeijer Brigitte M., Klein Twennaar Christian F., Kastelein John J. P., Franssen Eric J. F., Hutten Barbara A., Dallinga-Thie Geesje M., Stroes Erik S. G., Fliers Eric, Twickler Marcel T. B., Serlie Mireille J. Infusion of a Lipid Emulsion in Healthy Men Decreases the Serotonergic Response Neuroendocrinology 2012;95 (4):325-331 [PubMed]
• Hassing H. Carlijne, Mooij Hans, Guo Shuling, Monia Brett P., Chen Keyang, Kulik Wim, Dallinga-Thie Geesje M., Nieuwdorp Max, Stroes Erik S. G., Williams Kevin Jon Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia Hepatology (Baltimore, Md.) 2012;55 (6):1746-1753 [PubMed]
• Franssen Remco, Schimmel Alinda W. M., van Leuven Sander I., Wolfkamp Simone C. S., Stroes Erik S. G., Dallinga-Thie Geesje M. In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL Cholesterol 2012;2012:610741 [PubMed]
• Surendran R. P., Visser M. E., Heemelaar S., Wang J., Peter J., Defesche J. C., Kuivenhoven J. A., Hosseini M., Péterfy M., Kastelein J. J. P., Johansen C. T., Hegele R. A., Stroes E. S. G., Dallinga-Thie G. M. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia Journal of internal medicine 2012;272 (2):185-196 [PubMed]
• Hassing H. C., Surendran R. P., Mooij H. L., Stroes E. S., Nieuwdorp M., Dallinga-Thie G. M. Pathophysiology of hypertriglyceridemia BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2012;1821 (5):826-832 [PubMed]
• Krikken J. A., Dallinga-Thie G. M., Navis G., Dullaart R. P. F. Short term dietary sodium restriction decreases HDL cholesterol, apolipoprotein A-I and high molecular weight adiponectin in healthy young men: Relationships with renal hemodynamics and RAAS activation Nutrition, metabolism, and cardiovascular diseases 2012;22 (1):35-41 [PubMed]
• de Vries Rindert, Dikkeschei Bert D., Sluiter Wim J., Dallinga-Thie Geesje M., van Tol Arie, Dullaart Robin P. F. Statin and Fibrate Combination Does not Additionally Lower Plasma Cholesteryl Ester Transfer in Type 2 Diabetes Mellitus Clinical laboratory 2012;58 (11-12):1231-1239 [PubMed]
• Kootte R. S., Vrieze A., Holleman F., Dallinga-Thie G. M., Zoetendal E. G., de Vos W. M., Groen A. K., Hoekstra J. B. L., Stroes E. S., Nieuwdorp M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus Diabetes, obesity & metabolism 2012;14 (2):112-120 [PubMed]
• Vrieze Anne, van Nood Els, Holleman Frits, Salojärvi Jarkko, Kootte Ruud S., Bartelsman Joep F. W. M., Dallinga-Thie Geesje M., Ackermans Mariette T., Serlie Mireille J., Oozeer Raish, Derrien Muriel, Druesne Anne, van Hylckama Vlieg Johan E. T., Bloks Vincent W., Groen Albert K., Heilig Hans G. H. J., Zoetendal Erwin G., Stroes Erik S., de Vos Willem M., Hoekstra Joost B. L., Nieuwdorp Max Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome Gastroenterology 2012;143 (4):913-+ [PubMed]
• Dullaart R. P. F., Vergeer M., de Vries R., Kappelle P. J. W. H., Dallinga-Thie G. M. Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity Journal of internal medicine 2012;271 (5):490-498 [PubMed]

2011

• Le Goff W., Dallinga-Thie G. M. ABCG1: not as good as expected? Atherosclerosis 2011;219 (2):393-394 [PubMed]
• Johansen Christopher T., Wang Jian, Lanktree Matthew B., McIntyre Adam D., Ban Matthew R., Martins Rebecca A., Kennedy Brooke A., Hassell Reina G., Visser Maartje E., Schwartz Stephen M., Voight Benjamin F., Elosua Roberto, Salomaa Veikko, O'Donnell Christopher J., Dallinga-Thie Geesje M., Anand Sonia S., Yusuf Salim, Huff Murray W., Kathiresan Sekar, Cao Henian, Hegele Robert A. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia Arteriosclerosis, thrombosis, and vascular biology 2011;31 (8):1916-1926 [PubMed]
• van Wijk Jeroen P. H., Hoepelman Andy I. M., de Koning Eelco J. P., Dallinga-Thie Geesje, Rabelink Ton J., Cabezas Manuel Castro Differential Effects of Rosiglitazone and Metformin on Postprandial Lipemia in Patients With HIV-Lipodystrophy Arteriosclerosis, thrombosis, and vascular biology 2011;31 (1):228-233 [PubMed]
• Visser Maartje E. Dyslipidemia, sense, antisense or nonsense? 2011. 194p. ISBN 9789461081940. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisor: Dallinga-Thie G. M.)
• Vergeer Menno, Korporaal Suzanne J. A., Franssen Remco, Meurs Illiana, Out Ruud, Hovingh G. Kees, Hoekstra Menno, Sierts Jeroen A., Dallinga-Thie Geesje M., Motazacker Mohammad Mahdi, Holleboom Adriaan G., van Berkel Theo J. C., Kastelein John J. P., van Eck Miranda, Kuivenhoven Jan Albert Genetic Variant of the Scavenger Receptor BI in Humans New England journal of medicine 2011;364 (2):136-145 [PubMed]
• Sivapalaratnam S., Motazacker M. M., Maiwald S., Hovingh G. K., Kastelein J. J. P., Levi M. [=Marcel M.], Trip M. D., Dallinga-Thie G. M. Genome-wide association studies in atherosclerosis Current atherosclerosis reports 2011;13 (3):225-232 [PubMed]
• Kulozik Philipp, Jones Allan, Mattijssen Frits, Rose Adam J., Reimann Anja, Strzoda Daniela, Kleinsorg Stefan, Raupp Christina, Kleinschmidt Jürgen, Müller-Decker Karin, Wahli Walter, Sticht Carsten, Gretz Norbert, von Loeffelholz Christian, Stockmann Martin, Pfeiffer Andreas, Stöhr Sigrid, Dallinga-Thie Geesje M., Nawroth Peter P., Berriel Diaz Mauricio, Herzig Stephan Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia Cell metabolism 2011;13 (4):389-400 [PubMed]
• Holleboom Adriaan G., Karlsson Helen, Lin Ruei-Shiuan, Beres Thomas M., Sierts Jeroen A., Herman Daniel S., Stroes Erik S. G., Aerts Johannes M., Kastelein John J. P., Motazacker Mohammad M., Dallinga-Thie Geesje M., Levels Johannes H. M., Zwinderman Aeilko H., Seidman Jonathan G., Seidman Christine E., Ljunggren Stefan, Lefeber Dirk J., Morava Eva, Wevers Ron A., Fritz Timothy A., Tabak Lawrence A., Lindahl Mats, Hovingh G. Kees, Kuivenhoven Jan Albert Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man Cell metabolism 2011;14 (6):811-818 [PubMed]
• Kappelle Paul J. W. H., Perton Frank, Hillege Hans L., Dallinga-Thie Geesje M., Dullaart Robin P. F. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study Atherosclerosis 2011;217 (1):249-252 [PubMed]
• Orsoni Alexina, Saheb Samir, Levels Johannes H. M., Dallinga-Thie Geesje, Atassi Marielle, Bittar Randa, Robillard Paul, Bruckert Eric, Kontush Anatol, Carrié Alain, Chapman M. John LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection Journal of lipid research 2011;52 (12):2304-2313 [PubMed]
• de Vries Rindert, Kappelle Paul J. W. H., Dallinga-Thie Geesje M., Dullaart Robin P. F. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects Atherosclerosis 2011;217 (1):253-259 [PubMed]

2010

• Jakulj Lily, Vissers Maud N., Tanck Michael W. T., Hutten Barbara A., Stellaard Frans, Kastelein John J. P., Dallinga-Thie Geesje M. ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis Journal of lipid research 2010;51 (10):3016-3023 [PubMed]
• Franssen Remco Abormalities in lipoprotein metabolism: from dysfunctionla HHDL to abnormal processing of triglyceride-rich lipoproteins 2010. 272p. ISBN 9789461080929. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Stroes E. S. G., Dallinga-Thie G. M.)
• Kappelle Paul J. W. H., Dallinga-Thie Geesje M., Dullaart Robin P. F. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2010;1801 (1):89-94 [PubMed]
• Dullaart Robin P. F., Dallinga-Thie Geesje M. Beneficial effects of reconstituted HDL on ex vivo and in vitro platelet reactivity Clinical lipidology 2010;5 (2):167-171
• Dullaart Robin P. F., Kappelle Paul J. W. H., Dallinga-Thie Geesje M. Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome Atherosclerosis 2010;211 (2):393-396 [PubMed]
• Franssen Remco, Young Stephen G., Peelman Frank, Hertecant Jozef, Sierts Jeroen A., Schimmel Alinda W. M., Bensadoun André, Kastelein John J. P., Fong Loren, Dallinga-Thie Geesje M., Beigneux Anne P. Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects Circulation. Cardiovascular genetics 2010;3 (2):169-178 [PubMed]
• Dallinga-Thie G. M., Dullaart R. P. F. Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations? Atherosclerosis 2010;208 (2):328-329 [PubMed]
• Karalis Ioannis K., Bergheanu Sandrin C., Wolterbeek Ron, Dallinga-Thie Geesje M., Hattori Hiroaki, van Tol Arie, Liem Anho H., Wouter Jukema J. Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters Current medical research and opinion 2010;26 (10):2301-2313 [PubMed]
• Johansen Christopher T., Wang Jian, Lanktree Matthew B., Cao Henian, McIntyre Adam D., Ban Matthew R., Martins Rebecca A., Kennedy Brooke A., Hassell Reina G., Visser Maartje E., Schwartz Stephen M., Voight Benjamin F., Elosua Roberto, Salomaa Veikko, O'Donnell Christopher J., Dallinga-Thie Geesje M., Anand Sonia S., Yusuf Salim, Huff Murray W., Kathiresan Sekar, Hegele Robert A. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia Nature genetics 2010;42 (8):684-687 [PubMed]
• Alssema Marjan, El-Harchaoui Karim, Schindhelm Roger K., Diamant Michaela, Nijpels Giel, Kostense Piet J., Teerlink Tom, Heine Robert J., Dallinga-Thie Geesje M., Kuivenhoven Jan A., Dekker Jacqueline M., Scheffer Peter G. Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study Metabolism: clinical and experimental 2010;59 (6):854-860 [PubMed]
• Vergeer Menno, Boekholdt S. Matthijs, Sandhu Manjinder S., Ricketts Sally L., Wareham Nicholas J., Brown Morris J., de Faire Ulf, Leander Karin, Gigante Bruna, Kavousi Maryam, Hofman Albert, Uitterlinden Andre G., van Duijn Cornelia M., Witteman Jacqueline C. M., Jukema J. Wouter, Schadt Eric E., van der Schoot Ellen, Kastelein John J. P., Khaw Kay-Tee, Dullaart Robin P. F., van Tol Arie, Trip Mieke D., Dallinga-Thie Geesje M. Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility Circulation 2010;122 (5):470-U66 [PubMed]
• Dullaart Robin P. F., van den Berg Gerrit, van der Knaap Aafke M., Dijck-Brouwer Janneke, Dallinga-Thie Geesje M., Zelissen Peter M. J., Sluiter Wim J., van Beek André P. HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment European journal of endocrinology / European Federation of Endocrine Societies 2010;162 (2):227-234 [PubMed]
• Candini C., Schimmel A. W., Peter J., Bochem A. E., Holleboom A. G., Vergeer M., Dullaart R. P. F., Dallinga-Thie G. M., Hovingh G. K., Khoo K. L., Fasano T., Bocchi L., Calandra S., Kuivenhoven J. A., Motazacker M. M. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol Atherosclerosis 2010;213 (2):492-498 [PubMed]
• Vergeer Menno, Cohn Danny M., Boekholdt S. Matthijs, Sandhu Manjinder S., Prins Hester M., Ricketts Sally L., Wareham Nicholas J., Kastelein John J. P., Khaw Kay-Tee, Kamphuisen Pieter W., Dallinga-Thie Geesje M. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT Atherosclerosis 2010;211 (2):558-564 [PubMed]
• van Wijk Diederik F., Stroes Erik S. G., Dallinga-Thie G. M. Novel insights into anti-inflammatory actions of HDL Atherosclerosis 2010;212 (2):388-389 [PubMed]
• Gonzàlez Marta, Ribalta Josep, Vives Glòria, Iftimie Simona, Ferré Raimón, Plana Núria, Guardiola Montse, Dallinga-Thie Geesje, Masana Lluís, Castro Antoni Nuclear Magnetic Resonance Lipoprotein Subclasses and the APOE Genotype Influence Carotid Atherosclerosis in Patients with Systemic Lupus Erythematosus Journal of rheumatology 2010;37 (11):2259-2267 [PubMed]
• Avis H. J., Scheffer H. J., Kastelein J. J. P., Dallinga-Thie G. M., Wijburg F. A. Pink-creamy whole blood in a 3-month-old infant with a homozygous deletion in the lipoprotein lipase gene Clinical genetics 2010;77 (5):430-433 [PubMed]
• Dallinga-Thie Geesje M., Franssen Remco, Mooij Hans L., Visser Maartje E., Hassing H. Carlijne, Peelman Frank, Kastelein John J. P., Péterfy Miklós, Nieuwdorp Max The metabolism of triglyceride-rich lipoproteins revisited: New players, new insight Atherosclerosis 2010;211 (1):1-8 [PubMed]

2009

• Koeijvoets Kristel C. M. C., van der Net Jeroen B., Dallinga-Thie Geesje M., Steyerberg Ewout W., Mensink Ronald P., Kastelein John J. P., Sijbrands Eric J. G., Plat Jogchum ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia Atherosclerosis 2009;204 (2):453-458 [PubMed]
• Weinstein Michael M., Yin Liya, Beigneux Anne P., Davies Brandon S. J., Gin Peter, Estrada Kristine, Melford Kristan, Bishop Joseph R., Esko Jeffrey D., Dallinga-Thie Geesje, Fong Loren G., Bensadoun Andre, Young Stephen G. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice (vol 283, pg 34511, 2008) Journal of biological chemistry 2009;284 (6):4040
• Krikken J. A., Waanders F., Dallinga-Thie G. M., Dikkeschei L. D., Vogt L., Navis G. J., Dullaart R. P. F. Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin Expert opinion on therapeutic targets 2009;13 (5):497-504 [PubMed]
• Plat Jogchum, Brufau Gemma, Dallinga-Thie Geesje M., Dasselaar Margreet, Mensink Ronald P. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients Journal of nutrition 2009;139 (6):1143-1149 [PubMed]
• Kappelle Paul Jwh, Zwang Louwerens, Huisman Menno V., Banga Jan Dirk, Sluiter Wim J., Dallinga-Thie Geesje M., Dullaart Robin Pf Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein Expert opinion on therapeutic targets 2009;13 (7):743-751 [PubMed]
• Beigneux Anne P., Franssen Remco, Bensadoun André, Gin Peter, Melford Kristan, Peter Jorge, Walzem Rosemary L., Weinstein Michael M., Davies Brandon S. J., Kuivenhoven Jan A., Kastelein John J. P., Fong Loren G., Dallinga-Thie Geesje M., Young Stephen G. Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase Arteriosclerosis, thrombosis, and vascular biology 2009;29 (6):956-U447 [PubMed]
• van Oostrom A. J. H. H. M., Alipour A., Sijmonsma T. P., Verseyden C., Dallinga-Thie G. M., Plokker H. W. M., Castro Cabezas M. Comparison of different methods to investigate postprandial lipaemia Netherlands journal of medicine 2009;67 (1):13-20 [PubMed]
• Koeijvoets Kristel C. M. C., Mooijaart Simon P., Dallinga-Thie Geesje M., Defesche Joep C., Steyerberg Ewout W., Westendorp Rudi G. J., Kastelein John J. P., van Hagen P. Martin, Sijbrands Eric J. G. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia European heart journal 2009;30 (5):618-623 [PubMed]
• van Hoek Mandy, Dallinga-Thie Geesje M., Steyerberg Ewout W., Sijbrands Eric J. G. Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes European journal of human genetics 2009;17 (11):1386-1393 [PubMed]
• van Haperen Rien, Samyn Hannelore, van Gent Teus, Zonneveld Adri J., Moerland Matthijs, Grosveld Frank, Jansen Hans, Dallinga-Thie Geesje M., van Tol Arie, de Crom Rini Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2009;1791 (10):1031-1036 [PubMed]
• Vaessen Stefan F. C., Dallinga-Thie Geesje M., Ross Colin J. D., Splint Laura J., Castellani Lawrence W., Rensen Patrick C. N., Hayden Michael R., Schaap Frank G., Kuivenhoven Jan Albert Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels Journal of lipid research 2009;50 (5):880-884 [PubMed]
• Dallinga-Thie G. M., van Tol A., Dullaart R. P. F. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: role of phospholipid transfer protein BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2009;1791 (8):714-718 [PubMed]
• Reuwer Anne Q., Twickler Marcel Th B., Hutten Barbara A., Molema Frederique W., Wareham Nicholas J., Dallinga-Thie Geesje M., Bogorad Roman L., Goffin Vincent, Smink-Bol Mijke, Kastelein John J. P., Boekholdt S. Matthijs, Khaw Kay-Tee Prolactin Levels and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women Circulation. Cardiovascular genetics 2009;2 (4):389-U239 [PubMed]
• van Hoek M., van Tol A., van Vark-van der Zee L. C., Jansen H., Kastelein J. J. P., Sijbrands E. J. G., Dallinga-Thie G. M. Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes Current medical research and opinion 2009;25 (1):93-101 [PubMed]
• Hajer Gideon R., Dallinga-Thie Geesje M., van Vark-van der Zee Leonie C., Visseren Frank L. J. The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients Atherosclerosis 2009;202 (1):216-224 [PubMed]
• Harchaoui K. E. L., Visser M. E., Kastelein J. J. P., Stroes E. S., Dallinga-Thie G. M. Triglycerides and cardiovascular risk Current cardiology reviews 2009;5 (3):216-222 [PubMed]

2008

• Weinstein Michael M., Yin Liya, Beigneux Anne P., Davies Brandon S. J., Gin Peter, Estrada Kristine, Melford Kristan, Bishop Joseph R., Esko Jeffrey D., Dallinga-Thie Geesje M., Fong Loren G., Bensadoun André, Young Stephen G. Abnormal Patterns of Lipoprotein Lipase Release into the Plasma in GPIHBP1-deficient Mice Journal of biological chemistry 2008;283 (50):34511-34518 [PubMed]
• Moerland Matthijs, Samyn Hannelore, van Gent Teus, van Haperen Rien, Dallinga-Thie Geesje, Grosveld Frank, van Tol Arie, de Crom Rini Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis Arteriosclerosis, thrombosis, and vascular biology 2008;28 (7):1277-1282 [PubMed]
• Valkenburg Olivier, Steegers-Theunissen Regine P. M., Smedts Huberdina P. M., Dallinga-Thie Geesje M., Fauser Bart C. J. M., Westerveld Egbertine H., Laven Joop S. E. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study Journal of clinical endocrinology and metabolism 2008;93 (2):470-476 [PubMed]
• Pullinger Clive R., Aouizerat Bradley E., Movsesyan Irina, Durlach Vincent, Sijbrands Eric J., Nakajima Katsuyuki, Poon Annie, Dallinga-Thie Geesje M., Hattori Hiroaki, Green Lauri L., Kwok Pui-Yan, Havel Richard J., Frost Philip H., Malloy Mary J., Kane John P. An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients Journal of lipid research 2008;49 (8):1846-1854 [PubMed]
• de Haan Willeke, van der Hoogt Caroline C., Westerterp Marit, Hoekstra Menno, Dallinga-Thie Geesje M., Princen Hans M. G., Romijn Johannes A., Jukema J. Wouter, Havekes Louis M., Rensen Patrick C. N. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice Atherosclerosis 2008;197 (1):57-63 [PubMed]
• Westerveld H. E., Hoogendoorn M., de Jong A. W. F., Goverde A. J., Fauser B. C. J. M., Dallinga-Thie G. M. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights Pharmacology & therapeutics 2008;119 (3):223-241 [PubMed]
• Dallinga-Thie Geesje M., Dullaart Robin P. F., van Tol Arie Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development Current diabetes reports 2008;8 (1):65-70 [PubMed]
• Birjmohun Rakesh S., Hovingh G. Kees, Stroes Erik S. G., Hofstra Jorit J., Dallinga-Thie Geesje M., Meijers Joost C. M., Kastelein John J. P., Levi Marcel Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema Clinical therapeutics 2008;30 (12):2314-2323 [PubMed]
• Vergeer M., Dallinga-Thie G. M., Dullaart R. P. F., van Tol A. Evaluation of Phospoholipid Transfer Protein as a Therapeutic Target FUTURE LIPIDOLOGY 2008;3 (3):327-335
• van Hees Anneke M. J., Saris Wim H. M., Dallinga-Thie Geesje M., Hul Gabby B., Martinez J. Alfredo, Oppert Jean-Michel, Stich Vladimir, Astrup Arne, Arner Peter, Sørensen Thorkild I. A., Blaak Ellen E. Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution Journal of nutrition 2008;138 (12):2399-2405 [PubMed]
• Dullaart Robin P. F., Groen Albert K., Dallinga-Thie Geesje M., de Vries Rindert, Sluiter Wim J., van Tol Arie Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol European journal of endocrinology / European Federation of Endocrine Societies 2008;158 (1):53-60 [PubMed]
• van der Net Jeroen B., van Etten Jeroen, Yazdanpanah Mojgan, Dallinga-Thie Geesje M., Kastelein John J. P., Defesche Joep C., Koopmans Richard P., Steyerberg Ewout W., Sijbrands Eric J. G. Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia European heart journal 2008;29 (11):1370-1376 [PubMed]
• van der Net Jeroen B., Isaacs Aaron, Dallinga-Thie Geesje M., Kastelein John J. P., Defesche Joep C., Steyerberg Ewout W., Sijbrands Eric J. G. Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia Journal of hypertension 2008;26 (3):462-467 [PubMed]
• van Acker Bernadette A. C., Botma Gert-Jan, Zwinderman Aeilko H., Kuivenhoven Jan Albert, Dallinga-Thie Geesje M., Sijbrands Eric J. G., Boer Jolanda M. A., Seidell Jacob C., Jukema J. Wouter, Kastelein John J. P., Jansen Hans, Verhoeven Adrie J. M. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants Atherosclerosis 2008;200 (1):161-167 [PubMed]
• de Vries R., Groen A. K., Perton F. G., Dallinga-Thie G. M., van Wijland M. J. A., Dikkeschei L. D., Wolffenbuttel B. H. R., van Tol A., Dullaart R. P. F. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification Atherosclerosis 2008;196 (2):733-741 [PubMed]
• Hajer Gideon R., Dallinga-Thie Geesje M., van Vark-van der Zee Leonie C., Olijhoek Jobien K., Visseren Frank L. J. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial Clinical endocrinology 2008;69 (6):870-877 [PubMed]
• Dullaart Robin P. F., de Vries Rindert, Dallinga-Thie Geesje M., Sluiter Wim J., van Tol Arie Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases Clinical endocrinology 2008;68 (3):375-381 [PubMed]
• Berbée Jimmy F. P., van der Hoogt Caroline C., de Haas Carla J. C., van Kessel Kok P. M., Dallinga-Thie Geesje M., Romijn Johannes A., Havekes Louis M., van Leeuwen Henk J., Rensen Patrick C. N. Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis Intensive care medicine 2008;34 (5):907-911 [PubMed]
• Ye D., Kraaijeveld A. O., Grauss R. W., Willems S. M., van Vark-van der Zee L. C., de Jager S. C. A., Jauhiainen M., Kuivenhoven J. A., Dallinga-Thie G. M., Atsma D. E., Hogendoorn P. C. W., Biessen E. A. L., van Berkel T. J. C., Jukema J. W., van Eck M. Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes Journal of internal medicine 2008;264 (6):571-585 [PubMed]
• Krikken Jan A., Dallinga-Thie Geesje M., Navis Gerjan, Dullaart Robin P. F. Renin-angiotensin-aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects Expert opinion on therapeutic targets 2008;12 (11):1321-1328 [PubMed]
• Franssen Remco, Visser Maartje E., Kuivenhoven Jan Albert, Kastelein John J. P., Dallinga-Thie Geesje M., Stroes Erik S. G. Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target FUTURE LIPIDOLOGY 2008;3 (4):385-397
• Borggreve S. E., de Vries R., Dallinga-Thie G. M., Wolffenbuttel B. H. R., Groen A. K., van Tol A., Dullaart R. P. F. The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2008;1781 (1-2):10-15 [PubMed]
• Dullaart R. P. F., Borggreve S. E., Hillege H. L., Dallinga-Thie G. M. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer Scandinavian journal of clinical and laboratory investigation 2008;68 (2):99-105 [PubMed]
• Olijhoek Jobien K., Hajer Gideon R., van der Graaf Yolanda, Dallinga-Thie Geesje M., Visseren Frank L. J. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial Journal of cardiovascular pharmacology 2008;52 (2):145-150 [PubMed]
• Roeters van Lennep Henk W. O., Liem An Ho, Dunselman Peter H. J. M., Dallinga-Thie Geesje M., Zwinderman Aeilko H., Jukema J. Wouter The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study Current medical research and opinion 2008;24 (3):685-694 [PubMed]

2007

• Willemsen Judith M., Westerink Jan W., Dallinga-Thie Geesje M., van Zonneveld Anton-Jan, Gaillard Carlo A., Rabelink Ton J., de Koning Eelco J. P. Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes Journal of cardiovascular pharmacology 2007;49 (1):6-12 [PubMed]
• Birjmohun Rakesh S., Dallinga-Thie Geesje M., Kuivenhoven Jan Albert, Stroes Erik S. G., Otvos James D., Wareham Nicholas J., Luben Robert, Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Apolipoprotein A-II is inversely associated with risk of future coronary artery disease Circulation 2007;116 (18):2029-2035 [PubMed]
• Dallinga-Thie G. M., Zonneveld-de Boer A. J., van Vark-van der Zee L. C., van Haperen R., van Gent T., Jansen H., de Crom R., van Tol A. Appraisal of hepatic lipase and lipoprotein lipase activities in mice Journal of lipid research 2007;48 (12):2788-2791 [PubMed]
• Dullaart R. P. F., Dallinga-Thie G. M., Wolffenbuttel B. H. R., van Tol A. CETP inhibition in cardiovascular risk management: a critical appraisal European journal of clinical investigation 2007;37 (2):90-98 [PubMed]
• Dullaart R. P. F., Dallinga-Thie G. M., Wolffenbuttel B. H. R., van Tol A. CETP inhibition in cardiovascular risk management: a critical appraisal (vol 37, pg 90, 2007) European journal of clinical investigation 2007;37 (5):434
• Dullaart R. P. F., Dallinga-Thie G. M., Wolffenbuttel B. H. R., van Tol A. Cholesterol ester transfer proteine remming in de behandelstrategie bij cardiovasculair risico: een kritische beoordeling Diabetologia 2007;3:3-15
• van der Steeg Wim A., Hovingh G. Kees, Klerkx Anke H. E. M., Hutten Barbara A., Nootenboom Inge C., Levels Johannes H. M., van Tol Arie, Dallinga-Thie Gees M., Zwinderman Aeilko H., Kastelein John J. P., Kuivenhoven Jan Albert Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians Journal of lipid research 2007;48 (3):674-682 [PubMed]
• Dallinga-Thie Geesje M., Dullaart Robin P. F., van Tol Arie Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins Current opinion in lipidology 2007;18 (3):251-257 [PubMed]
• Bergheanu S. C., van Tol A., Dallinga-Thie G. M., Liem A., Dunselman P. H. J., van der Bom J. G., Jukema J. W. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol Current medical research and opinion 2007;23 (9):2235-2240 [PubMed]
• Dallongeville J., Gruson E., Dallinga-Thie G., Pigeyre M., Gomila S., Romon M. Effect of weight loss on the postprandial response to high-fat and high-carbohydrate meals in obese women European journal of clinical nutrition 2007;61 (6):711-718 [PubMed]
• van der Hoogt Caroline C., de Haan Willeke, Westerterp Marit, Hoekstra Menno, Dallinga-Thie Geesje M., Romijn Johannes A., Princen Hans M. G., Jukema J. Wouter, Havekes Louis M., Rensen Patrick C. N. Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression Journal of lipid research 2007;48 (8):1763-1771 [PubMed]
• van der Vleuten Gerly M., Isaacs Aaron, Zeng Wu-Wei, ter Avest Ewoud, Talmud Philippa J., Dallinga-Thie Geesje M., van Duijn Cornelia M., Stalenhoef Anton F. H., de Graaf Jacqueline Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 2007;1772 (1):81-88 [PubMed]
• Borggreve Susanna E., Hillege Hans L., Dallinga-Thie Geesje M., de Jong Paul E., Wolffenbuttel Bruce H. R., Grobbee Diederik E., van Tol Arie, Dullaart Robin P. F. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides European heart journal 2007;28 (8):1012-1018 [PubMed]
• de Graaf Jacqueline, van der Vleuten Gerly M., ter Avest Ewoud, Dallinga-Thie Geesje M., Stalenhoef Anton F. H. High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia Journal of clinical endocrinology and metabolism 2007;92 (4):1269-1275 [PubMed]
• Dullaart R. P. F., de Vries R., Dallinga-Thie G. M., van Tol A., Sluiter W. J. Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2007;1771 (1):113-118 [PubMed]
• Dullaart R. P. F., de Vries R., Dallinga-Thie G. M., van Tol A., Sluiter W. J. Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus (vol 1771, pg 113, 2007) BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2007;1771 (4):564
• Dullaart Robin P. F., Dallinga-Thie Geesje M., van Tol Arie Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo Clinical endocrinology 2007;67 (2):316-7; author reply 317 [PubMed]

2006

• Koeijvoets Kristel C. M. C., van Rossum Elisabeth F. C., Dallinga-Thie Geesje M., Steyerberg Ewout W., Defesche Joep C., Kastelein John J. P., Lamberts Steven W. J., Sijbrands Eric J. G. A functional polymorphism in the glucocorticoid receptor gene and its relation to cardiovascular disease risk in familial hypercholesterolemia Journal of clinical endocrinology and metabolism 2006;91 (10):4131-4136 [PubMed]
• Westerterp Marit, van der Hoogt Caroline C., de Haan Willeke, Offerman Erik H., Dallinga-Thie Geesje M., Jukema J. Wouter, Havekes Louis M., Rensen Patrick C. N. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice Arteriosclerosis, thrombosis, and vascular biology 2006;26 (11):2552-2559 [PubMed]
• Koeijvoets Kristel C. M. C., van der Net Jeroen B., Dallinga-Thie Geesje M., WSteyerberg Ewout, Sijbrands Eric J. G. Complex genetics of monogenic familial hypercholesterolemia FUTURE LIPIDOLOGY 2006;1 (5):527-538
• de Vries R., Dallinga-Thie G. M., Smit A. J., Wolffenbuttel B. H. R., van Tol A., Dullaart R. P. F. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus Diabetologia 2006;49 (2):398-404 [PubMed]
• Dallinga-Thie G. M., van Tol A., Hattori H., van Vark-van der Zee L. C., Jansen H., Sijbrands E. J. G. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes Diabetologia 2006;49 (7):1505-1511 [PubMed]
• Dallinga-Thie Geesje M., van Tol Arie, Hattori Hiroaki, Rensen Patrick C. N., Sijbrands Eric J. G. Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E? Diabetes 2006;55 (5):1491-1496 [PubMed]
• Twickler Marcel, Dallinga-Thie Geesje, Cramer Maarten-Jan Trojan horse hypothesis: inhaled airborne particles, lipid bullets, and atherogenesis JAMA 2006;295 (20):2354; author reply 2354-2354; author reply 2355 [PubMed]

2005

• de Vries Rindert, Perton Frank G., Dallinga-Thie Geesje M., van Roon Arie M., Wolffenbuttel Bruce H. R., van Tol Arie, Dullaart Robin P. F. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides Diabetes 2005;54 (12):3554-3559 [PubMed]
• Twickler Th. B., Dallinga-Thie G. M., Chapman M. J., Cohn J. S. Remnant lipoproteins and atherosclerosis Current atherosclerosis reports 2005;7 (2):140-147 [PubMed]
• Neve Bernadette, Fernandez-Zapico Martin E., Ashkenazi-Katalan Vered, Dina Christian, Hamid Yasmin H., Joly Erik, Vaillant Emmanuel, Benmezroua Yamina, Durand Emmanuelle, Bakaher Nicolas, Delannoy Valerie, Vaxillaire Martine, Cook Tiffany, Dallinga-Thie Geesje M., Jansen Hans, Charles Marie-Aline, Clément Karine, Galan Pilar, Hercberg Serge, Helbecque Nicole, Charpentier Guillaume, Prentki Marc, Hansen Torben, Pedersen Oluf, Urrutia Raul, Melloul Danielle, Froguel Philippe Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function Proceedings of the National Academy of Sciences of the United States of America 2005;102 (13):4807-4812 [PubMed]

2004

• Pruneta-Deloche Valérie, Sassolas Agnès, Dallinga-Thie Geesje M., Berthezène François, Ponsin Gabriel, Moulin Philippe Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes Journal of lipid research 2004;45 (5):859-865 [PubMed]
• Mar Rebecca, Pajukanta Päivi, Allayee Hooman, Groenendijk Martine, Dallinga-Thie Geesje, Krauss Ronald M., Sinsheimer Janet S., Cantor Rita M., de Bruin Tjerk W. A., Lusis Aldons J. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia Circulation research 2004;94 (7):993-999 [PubMed]
• Dallinga-Thie Geesje M., Berk-Planken Ingrid I. L., Bootsma Aart H., Jansen Hans Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides Diabetes care 2004;27 (6):1358-1364 [PubMed]
• Twickler T. B., Dallinga-Thie G. M., Cohn J. S., Chapman M. J. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype Circulation 2004;109 (16):1918-1925 [PubMed]
• Hofker M., Calabresi L., Jauhiainen M., Nimpf J., Rudling M., Talmud P., Mooser V., Dallinga-Thie G., von Eckardstein A., Staels B., Karpe F., Kuipers F. European Lipoprotein Club: report of the 26th ELC Annual Conference, Tutzing, 8-11 September 2003 Atherosclerosis 2004;173 (1):125-134 [PubMed]
• Sijbrands Eric J. G., Dallinga-Thie Geesje, Langendonk Janneke G. Molecular analysis of cardiovascular disease: some delay due to gene-environment interactions Seminars in vascular medicine 2004;4 (3):265-270 [PubMed]
• Probst Mario C. O., Thumann Harald, Aslanidis Charalampos, Langmann Thomas, Buechler Christa, Patsch Wolfgang, Baralle Francisco E., Dallinga-Thie Geesje M., Geisel Jürgen, Keller Christiane, Menys Valentine C., Schmitz Gerd Screening for functional sequence variations and mutations in ABCA1 Atherosclerosis 2004;175 (2):269-279 [PubMed]
• Dullaart R. P. F., de Vries R., Scheek L., Borggreve S. E., van Gent T., Dallinga-Thie G. M., Ito M., Nagano M., Sluiter W. J., Hattori H., van Tol A. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations Scandinavian journal of clinical and laboratory investigation 2004;64 (3):205-215 [PubMed]

2003

• Twickler T. B., Cramer M. J. M., Dallinga-Thie G. M., Chapman M. J., Erkelens D. W., Koppeschaar H. P. F. Adult-onset growth hormone deficiency: Relation of postprandial dyslipidemia to premature atherosclerosis Journal of clinical endocrinology and metabolism 2003;88 (6):2479-2488 [PubMed]
• van Venrooij Francine V., Stolk Ronald P., Banga Jan-Dirk, Sijmonsma Tjeerd P., van Tol Arie, Erkelens D. Willem, Dallinga-Thie Geesje M. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes Diabetes care 2003;26 (4):1216-1223 [PubMed]
• Bowyer David, Dallinga-Thie Geesje, von Eckardstein Arnold, Hofker Marten, Jauhiainen Matti, Mooser Vincent, Nimpf Johannes, Rudling Matts, Staels Bart, Talmud Philippa European lipoprotein club: report of the 25th ELC annual conference. Tutzing, 9-12 September 2002 Atherosclerosis 2003;167 (1):159-168 [PubMed]
• Twickler T. B., Dallinga-Thie G. M., Visseren F. L. J., de Vries W. R., Erkelens D. W., Koppeschaar H. P. F. Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration Journal of clinical endocrinology and metabolism 2003;88 (3):1228-1233 [PubMed]
• van Leeuwen Henk J., Heezius Eric C. J. M., Dallinga Geesje M., van Strijp Jos A. G., Verhoef Jan, van Kessel Kok P. M. Lipoprotein metabolism in patients with severe sepsis Critical care medicine 2003;31 (5):1359-1366 [PubMed]
• Ossewaarde M. E., Dallinga-Thie G. M., Bots M. L., van der Schouw Y. T., Rabelink T. J., Grobbee D. E., Westerveld H. T. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial European journal of clinical investigation 2003;33 (5):376-382 [PubMed]

2002

• de Sauvage Nolting Pernette R. W., Twickler Marcel B., Dallinga-Thie Geesje M., Buirma Rudolf J. A., Hutten Barbara A., Kastelein John J. P. Elevated remnant-like particles in heterozygous familial hypercholesterolemia and response to statin therapy Circulation 2002;106 (7):788-792 [PubMed]
• Dallinga-Thie G., Bowyer David, Dieplinger Hans, Funke Harald, Hofker Marten, Jauhiainen Matti, Nimpf Johannes, Staels Bart, Talmud Philippa, Tarugi Patricia European Lipoprotein Club: Report of the 24th ELC Annual Conference, Tutzing, 10-13 September 2001 Atherosclerosis 2002;162 (2):439-447 [PubMed]
• Keulen Eric T. P., Schaper Nicolaas C., Houben Alphons J. H. M., van Lin Josephine M. J. P., Lutgens Isabelle, Rijkers Kim, Dallinga-Thie Geesje M., de Bruin Tjerk W. A. Reduced structural and functional skin capillaries in familial combined hyperlipidemia affected men, associated with increased remnant-like lipoprotein cholesterol levels Atherosclerosis 2002;163 (2):355-362 [PubMed]
• Twickler Th B., Cramer M. J. M., Dallinga-Thie G. M., Erkelens D. W. The continuous postprandial state of man and its influence on atherosclerosis Netherlands heart journal 2002;10 (4):173-175 [PubMed]

2001

• Niemeijer-Kanters S. D., Dallinga-Thie G. M., de Ruijter-Heijstek F. C., Algra A., Erkelens D. W., Banga J. D., Jansen H. Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus Atherosclerosis 2001;156 (1):209-216 [PubMed]
• Wilmink H. W., Twickler M. B., Banga J. D., Dallinga-Thie G. M., Eeltink H., Erkelens D. W., Rabelink T. J., Stroes E. S. Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles Cardiovascular research 2001;50 (3):577-582 [PubMed]
• Dallinga-Thie G. M., Groenendijk M., Blom R. N., de Bruin T. W., de Kant E. Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin Journal of lipid research 2001;42 (9):1450-1456 [PubMed]
• Schreuder P. C., Twickler T. B., Wang T., Nakajima K., Erkelens D. W., Dallinga-Thie G. M. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects Atherosclerosis 2001;157 (1):145-150 [PubMed]
• Groenendijk M., Cantor R. M., de Bruin T. W., Dallinga-Thie G. M. New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia Journal of lipid research 2001;42 (2):188-194 [PubMed]
• Groenendijk M., Cantor R. M., de Bruin T. W., Dallinga-Thie G. M. The apoAI-CIII-AIV gene cluster Atherosclerosis 2001;157 (1):1-11 [PubMed]
• Twickler T. B., Dallinga-Thie G. M., Zelissen P. M., Koppeschaar H. P., Erkelens D. W. The atherogenic plasma remnant-like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients Clinical endocrinology 2001;55 (1):69-75 [PubMed]
• Berkplanken I., Hoogerbrugge N., Jansen H., Princen H. M. G., Huisman M. V., van de Ree M. A., Stolk R. P., van Venrooij F. V., Banga J. D., Dallinga-Thie G. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia - The DALI Study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia Diabetes care 2001;24 (8):1335-1341
• van Leeuwen H. J., van Beek A. P., Dallinga-Thie G. M., van Strijp J. A., Verhoef J., van Kessel K. P. The role of high density lipoprotein in sepsis Netherlands journal of medicine 2001;59 (3):102-110 [PubMed]
• Groenendijk M., Cantor R. M., Funke H., Dallinga-Thie G. M. Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia European journal of clinical investigation 2001;31 (10):852-859 [PubMed]
• Groenendijk M., de Bruin T. W., Dallinga-Thie G. M. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia Atherosclerosis 2001;158 (2):369-376 [PubMed]

2000

• Twickler T. B., Wilmink H. W., Schreuder P. C., Cabezas M. C., van Dam P. S., Koppeschaar H. P., Erkelens D. W., Dallinga-Thie G. M. Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency Journal of clinical endocrinology and metabolism 2000;85 (12):4683-4689 [PubMed]
• Twickler T. B., Dallinga-Thie G. M., de Valk H. W., Schreuder P. C., Jansen H., Cabezas M. C., Erkelens D. W. High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia Arteriosclerosis, thrombosis, and vascular biology 2000;20 (11):2422-2427 [PubMed]

1999

• Aouizerat B. E., Allayee H., Cantor R. M., Davis R. C., Lanning C. D., Wen P. Z., Dallinga-Thie G. M., de Bruin T. W., Rotter J. I., Lusis A. J. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11 American journal of human genetics 1999;65 (2):397-412 [PubMed]
• Groenendijk M., Cantor R. M., Blom N. H., Rotter J. I., de Bruin T. W., Dallinga-Thie G. M. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia Journal of lipid research 1999;40 (6):1036-1044 [PubMed]
• de Man F. H., van der Laarse A., Hopman E. G., Gevers Leuven J. A., Onkenhout W., Dallinga-Thie G. M., Smelt A. H. Dietary counselling effectively improves lipid levels in patients with endogenous hypertriglyceridemia: emphasis on weight reduction and alcohol limitation European journal of clinical nutrition 1999;53 (5):413-418 [PubMed]
• Aouizerat B. E., Allayee H., Cantor R. M., Dallinga-Thie G. M., Lanning C. D., de Bruin T. W., Lusis A. J., Rotter J. I. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q Arteriosclerosis, thrombosis, and vascular biology 1999;19 (11):2730-2736 [PubMed]

1998

• van Erpecum K. J., van Berge-Henegouwen G. P., Eckhardt E. R., Portincasa P., van de Heijning B. J., Dallinga-Thie G. M., Groen A. K. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform Hepatology (Baltimore, Md.) 1998;27 (6):1508-1516 [PubMed]
• Allayee H., Aouizerat B. E., Cantor R. M., Dallinga-Thie G. M., Krauss R. M., Lanning C. D., Rotter J. I., Lusis A. J., de Bruin T. W. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype American journal of human genetics 1998;63 (2):577-585 [PubMed]
• van Beek A. P., van Barlingen H. H., de Ruijter-Heijstek F. C., Jansen H., Erkelens D. W., Dallinga-Thie G. M., de Bruin T. W. Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity Journal of lipid research 1998;39 (2):322-332 [PubMed]

1997

• Dallinga-Thie G. M., van Linde-Sibenius Trip M., Rotter J. I., Cantor R. M., Bu X., Lusis A. J., de Bruin T. W. Complex genetic contribution of the apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia - Identification of different susceptibility haplotypes Journal of clinical investigation 1997;99 (5):953-961 [PubMed]

1996

• Dallinga-Thie G. M., Bu X. D., van Linde-Sibenius Trip M., Rotter J. I., Lusis A. J., de Bruin T. W. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III Journal of lipid research 1996;37 (1):136-147 [PubMed]
• Portincasa P., van Erpecum K. J., van de Meeberg P. C., Dallinga-Thie G. M., de Bruin T. W., van Berge-Henegouwen G. P. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy Hepatology (Baltimore, Md.) 1996;24 (3):580-587 [PubMed]
• de Bruin T. W., Dallinga-Thie G. M., Erkelens D. W. Familiaire gecombineerde hyperlipidemie Nederlands tijdschrift voor geneeskunde 1996;140 (43):2118-2121 [PubMed]
• de Bruin T. W., Mailly F., van Barlingen H. H., Fisher R., Castro Cabezas M., Talmud P., Dallinga-Thie G. M., Humphries S. E. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia European journal of clinical investigation 1996;26 (8):631-639 [PubMed]

1995

• Dallinga-Thie G. M., van Linde-Sibenius Trip M., Kock L. A., de Bruin T. W. Apolipoprotein E2/E3/E4 genotyping with agarose gels Clinical chemistry 1995;41 (1):73-75 [PubMed]

1987

• van Tol A., van 't Hooft F. M., van Gent T., Dallinga-Thie G. M. HDL subfractions, HDL receptors and HDL turnover Advances in experimental medicine and biology 1987;210:15-21 [PubMed]

1986

• Dallinga-Thie G. M., van't Hooft F. M., van Tol A. Comparison of the metabolic behavior of rat apolipoproteins A-I and A-IV, isolated from both lymph chylomicrons and serum high density lipoproteins International journal of biochemistry 1986;18 (4):383-388 [PubMed]
• Dallinga-Thie G. M., van Tol A., van't Hooft F. M., Groot P. H. E. Distribution of apolipoproteins A-I and A-IV among lipoprotein classes in rat mesenteric lymph, fractionated by molecular sieve chromatography BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM 1986;876 (1):108-115 [PubMed]
• Dallinga-Thie G. M., Schneijderberg V. L., van Tol A. Identification and characterization of rat serum lipoprotein subclasses. Isolation by chromatography on agarose columns and sequential immunoprecipitation Journal of lipid research 1986;27 (10):1035-1043 [PubMed]
• van Tol A., Dallinga-Thie G. M., van Gent T., van't Hooft F. M. SPECIFIC SATURABLE BINDING OF RAT HIGH-DENSITY-LIPOPROTEINS TO RAT-KIDNEY MEMBRANES BIOCHIMICA ET BIOPHYSICA ACTA 1986;876 (2):340-351 [PubMed]
• Dallinga-Thie G. M., van 't Hooft F. M., van Tol A. Tissue sites of degradation of high density lipoprotein apolipoprotein A-IV in rats Arteriosclerosis (Dallas, Tex.) 1986;6 (3):277-284 [PubMed]

1985

• Dallinga-Thie G. M., Groot P. H. E., van Tol A. Distribution of apolipoprotein A-IV among lipoprotein subclasses in rat serum Journal of lipid research 1985;26 (8):970-976 [PubMed]
• Dallinga-Thie G. M., Groot P. H., van Tol A. ELECTROIMMUNOASSAY OF RAT APOLIPOPROTEINS A-I, A-IV, AND E - A PROCEDURE FOR SAMPLE TREATMENT TO INCREASE THE SENSITIVITY IN DILUTED FRACTIONS Journal of lipid research 1985;26 (7):889-892 [PubMed]
• van't Hooft F. M., Dallinga-Thie G. M., van Tol A. LEUPEPTIN AS A TOOL FOR THE DETECTION OF THE SITES OF CATABOLISM OF RAT HIGH-DENSITY LIPOPROTEIN APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-E BIOCHIMICA ET BIOPHYSICA ACTA 1985;834 (1):75-84 [PubMed]

1984

• Dallinga-Thie G. M., van Tol A. Metabolism of rat serum high-density lipoprotein apolipoprotein A-IV Agents and actions. Supplements 1984;16:87-93 [PubMed]

1983

• Jansen H., Schoonderwoerd G. C., Dallinga-Thie G. M. SEPARATION OF RAT PLASMA HDL SUBFRACTIONS BY DENSITY GRADIENT CENTRIFUGATION AND THE EFFECT OF INCUBATION ON THESE FRACTIONS BIOCHIMICA ET BIOPHYSICA ACTA 1983;754 (3):271-278 [PubMed]

1980

• Brussaard J. H., Dallinga-Thie G., Groot P. H. E., Katan M. B. Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man. A controlled 8-week trial Atherosclerosis 1980;36 (4):515-527 [PubMed]

1979

• Bronsgeest-Schoute D. C., Hermus R. J., Dallinga-Thie G. M., Hautvast J. G. Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man. II. Effects of dietary cholesterol in a linoleic acid-poor diet American journal of clinical nutrition 1979;32 (11):2188-2192 [PubMed]
• Bronsgeest-Schoute D. C., Hermus R. J., Dallinga-Thie G. M., Hautvast J. G. Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man. III. The effect on serum cholesterol of removal of eggs from the diet of free-living habitually egg-eating people American journal of clinical nutrition 1979;32 (11):2193-2197 [PubMed]
• Hermus R. J., Dallinga-Thie G. M. SOYA, SAPONINS, AND PLASMA-CHOLESTEROL Lancet 1979;2 (8132):48 [PubMed]

1978

• PREIN A. E., THIE G. M., Alink G. M., Koeman J. H., Poels C. L. Cytogenetic changes in fish exposed to water of the river Rhine Science of the total environment 1978;9 (3):287-291 [PubMed]

1977

• TSAI A. C., THIE G. M., Lin C. R. Effect of cholesterol feeding on tissue lipid perioxidation, glutathione peroxidase activity and liver microsomal functions in rats and guinea pigs Journal of nutrition 1977;107 (2):310-319 [PubMed]